CVE-2017-2869 json
An exploitable code execution vulnerability exists in the OpenProducer functionality of Natus Xltek NeuroWorks 8.
published 2018-04-05 8 y ago modified 2026-06-17 4 mo ago also EUVD-2017-12010
- cvss
- 10.0
- version 3.0, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 2.6%
- EPSS 2.6% chance of exploitation in 30 days, percentile 85%
- public exploits
- 0
- none known
Summary
An exploitable code execution vulnerability exists in the OpenProducer functionality of Natus Xltek NeuroWorks 8. A specially crafted network packet can cause a stack buffer overflow resulting in code execution. An attacker can send a malicious packet to trigger this vulnerability.
Vendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSMA-18-165-01 updated cvss 10.0
Natus Xltek NeuroWorks
-
Natus Medical, Inc. (Natus) Natus Xltek NeuroWorks 8affected: vendor fix
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
Exploit prediction
2.62% chance of exploitation in the next 30 days, higher than 85% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.0 | 10.0 | CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H |
| NVD | 3.1 | 9.8 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
| NVD | 2.0 | 7.5 | AV:N/AC:L/Au:N/C:P/I:P/A:P |
Affected products
- Natus Medical Incorporated Natus
Classification
- Weakness
-
- CWE-787 Out-of-bounds Write
References
-
securityfocus.com
/bid/104490
vdb-entry, broken-link
-
talosintelligence.com
/vulnerability_reports/TALOS-2017-0375
third-party-advisory
Sources
- CVE List CVE-2017-2869
- NVD CVE-2017-2869
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.